Cutaneous alterations due to chemotherapy and chemoradiation are very frequent and may provoke even life-threatening complications augmenting morbidity and mortality. reports is the presence of a probable correlation between cutaneous toxicity and treatment performance in tumor individuals who have KS-176 been treated with novel drugs KS-176 such as nivolumab or pembrolizumab. Findings from these experiments … Continue reading Cutaneous alterations due to chemotherapy and chemoradiation are very frequent and may provoke even life-threatening complications augmenting morbidity and mortality